This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hasan, D. Articles by Vermeulen, M. Search for Related Content PubMed PubMed Citation Articles by Hasan, D. Articles by Vermeulen, M.

Stroke, Vol 20, 1156-1161, Copyright © 1989 by American Heart Association

ARTICLES

Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage

D Hasan, KW Lindsay, EF Wijdicks, GD Murray, PJ Brouwers, WH Bakker, J van Gijn and M Vermeulen
Department of Neurology, University Hospital Dijkzigt, Rotterdam, The Netherlands.

In this study with randomized controls, we administered fludrocortisone acetate to 46 of 91 patients with subarachnoid hemorrhage in an attempt to prevent excessive natriuresis and plasma volume depletion. Fludrocortisone significantly reduced the frequency of a negative sodium balance during the first 6 days (from 63% to 38%, p = 0.041). A negative sodium balance was significantly correlated with decreased plasma volume during both the first 6 days (p = 0.014) and during the entire 12-day study period (p = 0.004). Although fludrocortisone treatment tended to diminish the decrease in plasma volume, the difference was not significant (p = 0.188). More patients in the control group developed cerebral ischemia (31% vs. 22%) and, consequently, more control patients were treated with plasma volume expanders (24% vs. 15%), which may have masked the effects of fludrocortisone on plasma volume. Fludrocortisone therefore reduces natriuresis and remains of possible therapeutic benefit in the prevention of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

This article has been cited by other articles:

				P. Lee, G. R. D. Jones, and J. R. Center Successful Treatment of Adult Cerebral Salt Wasting With Fludrocortisone Arch Intern Med, February 11, 2008; 168(3): 325 - 326. [Full Text] [PDF]

				A. A. Onitilo, E. Kio, and S. A. R. Doi Tumor-Related Hyponatremia Clin. Med. Res., December 1, 2007; 5(4): 228 - 237. [Abstract] [Full Text] [PDF]

				Y. Katayama, J. Haraoka, H. Hirabayashi, T. Kawamata, K. Kawamoto, T. Kitahara, J. Kojima, T. Kuroiwa, T. Mori, N. Moro, et al. A Randomized Controlled Trial of Hydrocortisone Against Hyponatremia in Patients With Aneurysmal Subarachnoid Hemorrhage Stroke, August 1, 2007; 38(8): 2373 - 2375. [Abstract] [Full Text] [PDF]

				H.-J. Priebe Aneurysmal subarachnoid haemorrhage and the anaesthetist Br. J. Anaesth., July 1, 2007; 99(1): 102 - 118. [Abstract] [Full Text] [PDF]

				N. Moro, Y. Katayama, J. Kojima, T. Mori, and T. Kawamata Prophylactic Management of Excessive Natriuresis With Hydrocortisone for Efficient Hypervolemic Therapy After Subarachnoid Hemorrhage Stroke, December 1, 2003; 34(12): 2807 - 2811. [Abstract] [Full Text] [PDF]

				H. Kasuya, H. Onda, T. Yoneyama, T. Sasaki, and T. Hori Bedside Monitoring of Circulating Blood Volume After Subarachnoid Hemorrhage Stroke, April 1, 2003; 34(4): 956 - 960. [Abstract] [Full Text] [PDF]

				M J Brookes and T H Gould Cerebral salt wasting syndrome in meningoencephalitis: a case report J. Neurol. Neurosurg. Psychiatry, February 1, 2003; 74(2): 277 - 277. [Full Text] [PDF]

				L. Lennihan, S. A. Mayer, M. E. Fink, A. Beckford, M. C. Paik, H. Zhang, Y.-C. Wu, L. M. Klebanoff, E. C. Raps, and R. A. Solomon Effect of Hypervolemic Therapy on Cerebral Blood Flow After Subarachnoid Hemorrhage : A Randomized Controlled Trial Stroke, February 1, 2000; 31(2): 383 - 391. [Abstract] [Full Text] [PDF]